MYGN earnings
Myriad Genetics (MYGN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
MYGN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | -0.25 | -0.06 | -331.93% | $190.70M |
| Q1 2026 | May 5, 2026 | -0.09 | -0.06 | -50.00% | $200.40M |
| Q4 2025 | Feb 23, 2026 | 0.04 | -0.02 | 300.00% | $209.80M |
| Q3 2025 | Nov 3, 2025 | -0.13 | -0.01 | -1200.00% | $205.70M |
| Q2 2025 | Aug 5, 2025 | 0.05 | -0.01 | 600.00% | $213.10M |
| Q1 2025 | May 6, 2025 | -0.03 | -0.05 | 40.00% | $195.90M |
| Q4 2024 | Feb 24, 2025 | 0.03 | 0.03 | 0.00% | $210.60M |
| Q3 2024 | Nov 7, 2024 | 0.06 | 0.02 | 215.79% | $213.30M |
| Q2 2024 | Aug 6, 2024 | 0.05 | 0.01 | 509.01% | $211.50M |
| Q1 2024 | May 7, 2024 | -0.01 | -0.11 | 90.91% | $202.20M |
| Q4 2023 | Feb 27, 2024 | 0.04 | 0.01 | 214.22% | $196.60M |
| Q3 2023 | Nov 6, 2023 | -0.03 | -0.08 | 62.50% | $191.90M |
| Aug 3, 2023 | -0.08 | -0.10 | 20.00% | – | |
| May 3, 2023 | -0.21 | -0.19 | -10.53% | – | |
| Feb 28, 2023 | -0.12 | -0.16 | 25.00% | – | |
| Nov 1, 2022 | -0.19 | -0.06 | -216.67% | – | |
| Aug 4, 2022 | 0.04 | 0.01 | 300.00% | – | |
| May 5, 2022 | -0.03 | -0.05 | 40.00% | – | |
| Feb 24, 2022 | -0.02 | -0.02 | -14.29% | – | |
| Nov 2, 2021 | -0.02 | 0.01 | -300.00% | – |
- MYGN reports next on Nov 4, 2026, with EPS of -0.20 expected.
- MYGN beat EPS estimates in 90 of its last 121 reports.
Updated 2026-11-05 12:51 UTC